This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Delta 9 Cannabis Temettü

Temettü kriter kontrolleri 0/6

Delta 9 Cannabis does not have a record of paying a dividend.

Anahtar bilgiler

n/a

Temettü verimi

-78.1%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-78.1%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

It's Unlikely That Shareholders Will Increase Delta 9 Cannabis Inc.'s (TSE:DN) Compensation By Much This Year

Jun 21

It's Down 29% But Delta 9 Cannabis Inc. (TSE:DN) Could Be Riskier Than It Looks

May 10

Delta 9 Cannabis Inc.'s (TSE:DN) Shares Leap 122% Yet They're Still Not Telling The Full Story

Mar 26

Market Might Still Lack Some Conviction On Delta 9 Cannabis Inc. (TSE:DN) Even After 122% Share Price Boost

Mar 26

Is Delta 9 Cannabis (TSE:DN) Using Too Much Debt?

Sep 09

Delta 9 Cannabis Inc. (TSE:DN) Not Doing Enough For Some Investors As Its Shares Slump 27%

Jul 28

John Arbuthnot Is The Co-Founder of Delta 9 Cannabis Inc. (TSE:DN) And They Just Picked Up 1.0% More Shares

Dec 24

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Insufficient data to determine if DN's dividends per share have been stable in the past.

Büyüyen Temettü: Insufficient data to determine if DN's dividend payments have been increasing.

Piyasaya Karşı Temettü Getirisi

Delta 9 Cannabis Piyasaya Karşı Temettü Getirisi

DN temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (DN)	n/a
Pazarın Alt %25'i (CA)	1.8%
Pazarın En İyi %25'i (CA)	6.1%
Sektör Ortalaması (Pharmaceuticals)	2.3%
Analist tahmini (DN) (3 yıla kadar)	n/a

Önemli Temettü: Unable to evaluate DN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Yüksek Temettü: Unable to evaluate DN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Insufficient data to calculate DN's payout ratio to determine if its dividend payments are covered by earnings.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as DN has not reported any payouts.

This company listing is no longer active

Delta 9 Cannabis Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

FIKA entered into a binding term sheet agreement to acquire Cannabis retail store business and the logistics and distribution business of Delta 9 Cannabis Inc. (TSX:DN).

It's Unlikely That Shareholders Will Increase Delta 9 Cannabis Inc.'s (TSE:DN) Compensation By Much This Year

First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.02 loss in 1Q 2023)

It's Down 29% But Delta 9 Cannabis Inc. (TSE:DN) Could Be Riskier Than It Looks

Delta 9 Cannabis Inc., Annual General Meeting, Jun 28, 2024

Co-Founder exercised options to buy CA$31k worth of stock.

Full year 2023 earnings released: CA$0.10 loss per share (vs CA$0.22 loss in FY 2022)

Delta 9 Cannabis Inc.'s (TSE:DN) Shares Leap 122% Yet They're Still Not Telling The Full Story

Market Might Still Lack Some Conviction On Delta 9 Cannabis Inc. (TSE:DN) Even After 122% Share Price Boost

New major risk - Shareholder dilution

Third quarter 2023 earnings released: CA$0.03 loss per share (vs CA$0.06 loss in 3Q 2022)

Delta 9 Cannabis Inc. to Report Q3, 2023 Results on Nov 14, 2023

Is Delta 9 Cannabis (TSE:DN) Using Too Much Debt?

New major risk - Shareholder dilution

Second quarter 2023 earnings released: CA$0.02 loss per share (vs CA$0.04 loss in 2Q 2022)

New major risk - Share price stability

Delta 9 Cannabis Inc. (TSE:DN) Not Doing Enough For Some Investors As Its Shares Slump 27%

Delta 9 Cannabis Inc. to Report Q2, 2023 Results on Aug 14, 2023

Co-Founder recently sold CA$99k worth of stock

First quarter 2023 earnings released: CA$0.02 loss per share (vs CA$0.037 loss in 1Q 2022)

Delta 9 Cannabis Inc. to Report Q1, 2023 Results on May 15, 2023

Delta 9 Cannabis Inc. to Report Q4, 2022 Results on Mar 31, 2023

Co-Founder recently sold CA$52k worth of stock

Delta 9 Cannabis Inc. Announces Changes to Board of Directors

Third quarter 2022 earnings released: CA$0.06 loss per share (vs CA$0.011 loss in 3Q 2021)

Price target decreased to CA$0.80

Insufficient new directors

Delta 9 Cannabis Inc. Provides Earnings Guidance for the Quarter and Nine Months Ended September 30, 2022

Delta 9 Cannabis Inc. to Report Q3, 2022 Results on Nov 14, 2022

Delta 9 Cannabis Inc. (TSX:DN) acquired All or Substantially All Assets from 10552763 Canada Corp.

Does Delta 9 Cannabis (TSE:DN) Have A Healthy Balance Sheet?

Price target decreased to CA$0.80

Second quarter 2022 earnings released: CA$0.04 loss per share (vs CA$0.014 loss in 2Q 2021)

Delta 9 Cannabis Inc. (TSX:DN) entered into an asset purchase agreement to acquire all or Substantially all assets of 10552763 Canada Corp. for CAD 3.25 million.

Joanne Duhoux-Defehr Resigns from Board of Directors of Delta 9 Cannabis Inc

Delta 9 Cannabis Inc. has completed a Composite Units Offering in the amount of CAD 2 million.

Delta 9 Cannabis Inc. has completed a Composite Units Offering in the amount of CAD 2 million.

Price target decreased to CA$0.95

First quarter 2022 earnings released: CA$0.04 loss per share (vs CA$0.042 loss in 1Q 2021)

Delta 9 Cannabis Inc. Provides Revenue Guidance for the Three Months Period Ended March 31, 2022

Delta 9 Cannabis Inc., Annual General Meeting, Jun 29, 2022

Insufficient new directors

Full year 2021 earnings released: CA$0.11 loss per share (vs CA$0.072 loss in FY 2020)

Delta 9 Cannabis Inc. announced that it has received CAD 9.6 million in funding from Sundial Growers Inc.

Delta 9 Cannabis Inc. Provides Preliminary Unaudited Earnings Guidance for the Fourth Quarter and Year Ending December 31, 2021

Is Delta 9 Cannabis (TSE:DN) A Risky Investment?

Insufficient new directors

Third quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.07 loss in 3Q 2020)

Independent Director recently sold CA$126k worth of stock

Delta 9 Cannabis (TSE:DN) Is Making Moderate Use Of Debt

Price target increased to CA$1.13

Second quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.01 loss in 2Q 2020)

Delta 9 Cannabis Inc. Announces Health Canada Approval for Perimeter Expansion and Vault Area

Price target decreased to CA$1.04

Co-Founder exercised options to buy CA$63k worth of stock.

Co-Founder recently bought CA$53k worth of stock

Co-Founder recently bought CA$53k worth of stock

Delta 9 Cannabis Inc. Provides Revenue Guidance for the Three-Month and Six-Month Period Ending June 30, 2021

Co-Founder recently sold CA$138k worth of stock

Consensus revenue estimates fall to CA$66.3m

Co-Founder recently sold CA$115k worth of stock

First quarter 2021 earnings released: EPS CA$0.04 (vs CA$0.023 in 1Q 2020)

Delta 9 Cannabis Inc. Provides Revenue Guidance for the First Quarter Ending March 31, 2021

Delta 9 Cannabis (TSE:DN) Is Carrying A Fair Bit Of Debt

Full year 2020 earnings released: CA$0.07 loss per share (vs CA$0.16 profit in FY 2019)

Delta 9 Cannabis Inc. Provides Update on Strategic Cooperation Agreement with F1NE Cannabis Cultivation LTD

Delta 9 Cannabis Inc. Launches Province Wide Delivery in Saskatchewan and Reserve Online in Alberta

Delta 9 Cannabis Inc. to Report Q4, 2020 Results on Mar 30, 2021

Delta 9 Achieves Milestone in Agreement with Micro Cultivation Partner

New 90-day low: CA$0.49

Independent Director recently sold CA$75k worth of stock

Independent Director recently sold CA$75k worth of stock

Co-Founder recently bought CA$98k worth of stock

Delta 9 Achieves Milestone in Agreement with Micro Cultivation Partner